120 related articles for article (PubMed ID: 37451662)
1. Small-molecular cyclic peptide exerts viability suppression effects on HepG2 cells via triggering p53 apoptotic pathways.
Zhang H; Zhang H; Wang J; Fan L; Mu W; Jin Y; Wang Z
Chem Biol Interact; 2023 Sep; 382():110633. PubMed ID: 37451662
[TBL] [Abstract][Full Text] [Related]
2. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
3. Shentao Ruangan formula promotes apoptosis via the E2F2-p53 pathway in hepatocellular carcinoma.
Zeng Z; Jiang W; Kan J; Zhang D; Li R; He F; Hu Y; Li X; Zhang E; Cao Z
Phytomedicine; 2023 Jan; 109():154565. PubMed ID: 36610125
[TBL] [Abstract][Full Text] [Related]
4. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L
J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729
[TBL] [Abstract][Full Text] [Related]
5. Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53.
Sun YY; Xiao L; Wang D; Ji YC; Yang YP; Ma R; Chen XH
Int J Oncol; 2017 Mar; 50(3):847-852. PubMed ID: 28098861
[TBL] [Abstract][Full Text] [Related]
6. Antihepatocellular Carcinoma Potential of Tetramethylpyrazine Induces Cell Cycle Modulation and Mitochondrial-Dependent Apoptosis: Regulation of p53 Signaling Pathway in HepG2 Cells In Vitro.
Bi L; Yan X; Chen W; Gao J; Qian L; Qiu S
Integr Cancer Ther; 2016 Jun; 15(2):226-36. PubMed ID: 27179035
[TBL] [Abstract][Full Text] [Related]
7. The α-iso-cubebenol compound isolated from Schisandra chinensis induces p53-independent pathway-mediated apoptosis in hepatocellular carcinoma cells.
Kim JE; Kim SG; Goo JS; Park DJ; Lee YJ; Hwang IS; Lee HR; Choi SI; Lee YJ; Oh CH; Choi YW; Hwang DY
Oncol Rep; 2012 Sep; 28(3):1103-9. PubMed ID: 22736046
[TBL] [Abstract][Full Text] [Related]
8. Rapeseed peptide inhibits HepG2 cell proliferation by regulating the mitochondrial and P53 signaling pathways.
Ma K; Wang Z; Ju X; Huang J; He R
J Sci Food Agric; 2023 Feb; 103(3):1474-1483. PubMed ID: 36168817
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
10. An oral 2-hydroxypropyl-β-cyclodextrin-loaded spirooxindole-pyrrolizidine derivative restores p53 activity via targeting MDM2 and JNK1/2 in hepatocellular carcinoma.
Gao X; Wei M; Shan W; Liu Q; Gao J; Liu Y; Zhu S; Yao H
Pharmacol Res; 2019 Oct; 148():104400. PubMed ID: 31425749
[TBL] [Abstract][Full Text] [Related]
11. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
[TBL] [Abstract][Full Text] [Related]
12. Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells.
Zhang YY; Zhou LM
Eur J Pharmacol; 2013 Jan; 698(1-3):137-44. PubMed ID: 23178529
[TBL] [Abstract][Full Text] [Related]
13. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L
Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374
[TBL] [Abstract][Full Text] [Related]
14. Fusaric Acid Induces DNA Damage and Post-Translational Modifications of p53 in Human Hepatocellular Carcinoma (HepG
Ghazi T; Nagiah S; Tiloke C; Sheik Abdul N; Chuturgoon AA
J Cell Biochem; 2017 Nov; 118(11):3866-3874. PubMed ID: 28387973
[TBL] [Abstract][Full Text] [Related]
15. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA induced cell death via miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular carcinoma cells.
Ren X; Wang C; Xie B; Hu L; Chai H; Ding L; Tang L; Xia Y; Dou X
Eur J Pharmacol; 2017 Feb; 796():233-241. PubMed ID: 27894814
[TBL] [Abstract][Full Text] [Related]
17. Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells.
Wang H; Ye Y; Chui JH; Zhu GY; Li YW; Fong DW; Yu ZL
Oncol Rep; 2010 Sep; 24(3):647-51. PubMed ID: 20664969
[TBL] [Abstract][Full Text] [Related]
18. Walsuronoid B induces mitochondrial and lysosomal dysfunction leading to apoptotic rather than autophagic cell death via ROS/p53 signaling pathways in liver cancer.
Geng YD; Zhang C; Lei JL; Yu P; Xia YZ; Zhang H; Yang L; Kong LY
Biochem Pharmacol; 2017 Oct; 142():71-86. PubMed ID: 28673807
[TBL] [Abstract][Full Text] [Related]
19. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells.
Dai Q; Yin Y; Liu W; Wei L; Zhou Y; Li Z; You Q; Lu N; Guo Q
Int J Biochem Cell Biol; 2013 Jul; 45(7):1468-78. PubMed ID: 23612020
[TBL] [Abstract][Full Text] [Related]
20. Ginkgo biloba Extract Mechanism Inhibits Hepatocellular Carcinoma through the Nuclear Factor-κB/p53 Signaling Pathway.
Wang R; Shao X; Yang J; Liu Z; Chew L; Shao Y
J Environ Pathol Toxicol Oncol; 2020; 39(2):179-189. PubMed ID: 32749126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
